Ellington Management Group’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-303
Closed -$356K 952
2018
Q1
$356K Buy
+303
New +$335K 0.03% 523
2017
Q3
Sell
-87
Closed -$100K 923
2017
Q2
$100K Sell
87
-41
-32% -$49.9K 0.01% 597
2017
Q1
$148K Sell
128
-19
-13% -$18.3K 0.01% 622
2016
Q4
$154K Buy
+147
New +$66.7K 0.02% 472
2015
Q4
Sell
-182
Closed -$162K 887
2015
Q3
$162K Buy
+182
New +$166K 0.05% 614
2015
Q2
Sell
-124
Closed -$177K 944
2015
Q1
$177K Buy
+124
New +$157K 0.04% 609

Other funds holding HSTO

Ellington Management Group's HSTO Position: Q2 2018 in Review

Ellington Management Group sold out of Histogen Inc. Common Stock (HSTO) in Q2 2018, closing a stake of 303 shares — an estimated $356K sold.

Ellington Management Group first reported a position in HSTO in Q1 2015 and held it in 6 quarters. The position peaked at $356K in Q1 2018. 61 funds tracked by Wall St. Rank hold HSTO as of Q2 2018.

  • Ellington Management Group reported no remaining Histogen Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Ellington Management Group sold 303 Histogen Inc. Common Stock shares in Q2 2018, an estimated $356K.
  • Ellington Management Group first reported a position in Histogen Inc. Common Stock in Q1 2015 and held it in 6 quarters.
  • Ellington Management Group's Histogen Inc. Common Stock position peaked at $356K in Q1 2018.
  • 61 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2018.

Based on Ellington Management Group's 13F filing for Q2 2018, filed 14 Aug 2018.